⚖️ Courts, Calendars, And A Market In Motion

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

TToday’s story is not one headline. It is a stack of clocks. Rhode Island is in federal court over licensing design. Florida campaigns are back to zero. Ohio has weeks, not months, to decide the fate of hemp beverages. Meanwhile hospital systems are planning for rescheduling as if it will happen, even if Washington has not finished the paperwork. The market moves where governance moves.

Today’s edition is supported by Wispr Flow and The Deep View. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.

⚖️ Licensing Under Litigation
🗳️ Ballot Mechanics Matter
🏥 Institutional Preparation

🥤 Cann’s CEO Goes To Washington As The Hemp Deadline Closes In

Jake Bullock, CEO of Cann, is lobbying Capitol Hill for an extension and a federal framework as the November spending law tightens the federal hemp definition and effectively wipes out most hemp derived THC drinks later this year. Bullock expects retail buyers to start cutting purchase orders after July to avoid getting stuck with inventory ahead of the Nov. 12th off shelf deadline. The industry pitch is regulation that looks like alcohol, including federal age gating and taxation, plus a lane for disciplined low dose beverages to stay lawful. Opponents are leaning on youth access and marketing concerns, while regulated marijuana businesses argue the Farm Bill channel has avoided taxes and guardrails. If Congress does nothing, the squeeze hits distribution first, then cash flow, then brand survival, and the remainder of the category migrates to the least accountable outlets. (The Wall Street Journal)

⚕️ Dr. Oz Puts “High Dose Hemp” In The Policy Crosshairs

CMS Administrator Mehmet Oz warned about substitution away from alcohol and singled out high dose hemp and CBD as a problem. That posture matters because federal rhetoric becomes drafting language, then procurement and enforcement priorities, long before courts get a clean shot at boundaries. The risk is a definition that punishes age gated low dose beverage models that behave like regulated consumer goods while failing to choke off synthetic and gray market channels. Hospital systems and payers also hear this and plan conservatively, since Medicare adjacency makes counsel skittish. Expect disciplined brands to push hard for a narrower federal distinction that separates dosage, age gating, and manufacturing controls from the headline grabbing outliers. (Marijuana Moment)

🗓️ Schedule III Talk Shifts To September Calculus

Two months after President Trump signed an executive order directing the move to Schedule III, the timeline still looks stalled in public view. Jeff Guillot of Guillot Consulting pegged fall as the most plausible finish and floated September as the clean window ahead of midterms, while Attorney General Pam Bondi has stayed quiet in recent congressional testimony. Steven Ernest of Chicago Atlantic questioned whether Washington is ready to deliver anything fast, even with a Republican White House talking reform, and Vince Ning of Nabis leaned optimistic while admitting the process is opaque. The planning problem is the real market story: tax posture, debt terms, and M&A timelines cannot price a change that has no visible runway. Operators will keep budgeting for today’s rules, and boards will keep demanding contingency decks for tomorrow’s, which is expensive management in the worst way. (GreenState)

🧨 Industry Infighting Gives Rollback Campaigns A Cleaner Argument

Andrew DeAngelo argues the cannabis ecosystem is feeding its own opposition as licensed marijuana operators and hemp sellers attack each other using public health language that prohibition groups can reuse. He points to SAM Action Inc and Smart Approaches to Marijuana, led by Dr. Kevin Sabet, funding repeal efforts in Massachusetts and Maine and backing rollback pressure in Arizona. He frames the 2025 federal hemp clampdown as Exhibit A, with a one year compliance clock and an industry sprint for a legislative fix that has not arrived. Missouri and Maryland show how executive actions and court fights can harden enforcement posture and produce sweeping statements about legality that outlive the facts that created them. If the ecosystem wants durable legality, it needs a shared regulatory standard for all intoxicating THC products that survives a hostile hearing room. (Forbes)

🥤 Ohio Hemp Beverage Makers Face A March 20th Shelf Drop

Ohio hemp beverage producers are winding down inventory ahead of March 20th after Governor Mike DeWine vetoed the Senate Bill 56 carveout that would have kept these drinks in breweries and bars through the end of 2026. The last six months delivered whiplash: an executive order with a 0.5 milligram per serving threshold, a court block, a legislative rewrite, then a veto that removed the runway. Jana Hrdinová at Ohio State ties the category to the 2018 federal hemp definition and the loophole that allowed intoxicating products to scale faster than consumer safety rules. Collin Castore of Seventh Son describes a brewery model that pursued approvals, labeled 21 and over, and tested, while retailers recall the early Delta 8 wave that spooked policymakers. The immediate effect is a channel reset that hits the most compliant local producers first, while demand either shifts into the marijuana system or finds a less disciplined route. (Columbus Monthly)

🌾 Rural Ohio Farmers Try To Freeze SB 56 At The Ballot Box

Hemp farmers in rural Ohio are backing a referendum effort to repeal Senate Bill 56 and pause the March 20th crackdown. Joey Ellwood of Modern Remedies frames the fight as rural economic survival and personal liberty tied to lawful products that now get zeroed out. Senate President Rob McColley is selling the ban as a consumer safety move, with youth access and sourcing as the core justification. The campaign says it needs 250,000 signatures by mid March, and success would suspend the law until a November statewide vote. If they fall short, Ohio shifts from policy debate to enforcement reality in weeks, and that uncertainty will do as much damage as the statute itself. (News 5 Cleveland)

⚖️ Rhode Island Asks Court To Toss A Licensing Lawsuit With National Implications

Rhode Island regulators are asking federal court to dismiss a suit challenging the state’s adult use licensing structure, including resident preference and pieces of the equity framework. This is the same constitutional lane that has disrupted early rollouts elsewhere, since dormant commerce clause arguments target any system that favors in state applicants. The procedural fight matters because remedies can arrive fast, including a pause on licensing while standing and merits get sorted. That converts an agency calendar into a litigation calendar, and investors hate calendars they cannot trust. If Rhode Island loses ground here, the next iteration of equity design will be built under a court clock, not a policy clock. (Law360)

🗳️ Florida Zeroes Out Ballot Signatures As Litigation Drags On

Florida election officials reset signature counts to zero for multiple legalization campaigns amid ongoing legal challenges and petition compliance problems. The reset wipes out months of field work and pushes organizers back into qualification mechanics rather than voter persuasion. Florida’s initiative system is intentionally unforgiving, and campaigns bleed money when compliance becomes the main event. Donors respond to probability, and probability follows court calendars and verification rules, not vibes. The net effect is delay, higher burn, and another cycle where legalization momentum gets trapped in process.(Marijuana Moment)

🚚 Massachusetts Weighs A Delivery Exclusivity Extension With THC Group On The Record

The Massachusetts Cannabis Control Commission is weighing an extension of delivery exclusivity through April 2029 with the current runway set to expire April 1st. We submitted testimony on behalf of THC Group urging the Commission to pair exclusivity with a defined minority investment safe harbor and a clear transition pathway that allows delivery licensees to attract capital, scale, and eventually exit without triggering unpredictable ownership and control outcomes. The testimony also supports formalizing the Secret Shopper Program with chain of custody, storage controls, tolerance bands, confirmatory testing triggers, and reserve sample retention that can hold up in adjudicatory proceedings. Exclusivity buys time, but time alone does not build durable equity outcomes without capital access and predictable rules of the road. The Commission now has a choice between a defensible market mechanic and another annual cycle of fragile fixes. (WWLP)

🤮 Testing Rules Miss A Mycotoxin Question That Will Not Stay Quiet

A University of Colorado researcher is warning that state mandated cannabis testing can miss mycotoxins produced by mold, including Fusarium compounds that may persist even after remediation. The reporting ties that blind spot to concerns about cannabis hyperemesis syndrome and severe vomiting episodes, with a pointed observation: no one finds a problem if no one tests for it. Colorado also does not require remediated product that previously failed mold testing to carry a remediation disclosure, which keeps consumers and buyers in the dark. Regulators have downplayed Fusarium as widespread, but the absence of a testing panel makes that confidence hard to evaluate. Expect pressure to expand contaminant panels and tighten remediation disclosure before the next recall cycle lands in court filings and headlines. (MJBizDaily)

🧾 Maryland Hits Rise Joppa With A Six Figure Fine And Tight Compliance Terms

The Maryland Cannabis Administration issued a $100,000 civil fine against MESHOW LLC, operator of Rise Joppa, under a Feb. 2nd consent order tied to inspections from October 2024 through November 2025. Regulators alleged repeated oversales above personal use limits and adult use sales of high potency edibles reserved for medical, alongside inventory irregularities in Metrc. Investigators also cited staff processing fake purchases to zero out lots instead of reporting discrepancies, which is the kind of conduct that converts a compliance issue into a credibility issue. The company pointed to point of sale integration problems and said it added warning prompts and redundancies. The state imposed an 18 month compliance regime that includes training, third party auditing, and SOP revisions, and that posture will echo across the market as a warning shot on oversales and inventory controls. (Outlaw Report)

🏥 Hospitals Move To Integrate Medical Cannabis As Federal Risk Shifts

Connecticut lawmakers are advancing legislation to permit registered medical marijuana patients to access cannabis in hospital settings. This fits a broader state trend as health systems plan for rescheduling, research partnerships, and a more normalized federal posture. Hospitals care about protocols: medication reconciliation, dosing documentation, impairment monitoring, storage and chain of custody, and interactions with controlled substance policies. Research dollars sharpen the incentive, since IRBs, funders, and academic partners move quickly once barriers loosen and counsel can write clearer rules. The practical outcome is steady alignment between state medical programs and mainstream inpatient operations, even before Congress delivers a comprehensive fix. (Marijuana Moment)